Extending your reach in minimally invasive spinal procedures is now a reality – with the new MagnetOs™ MIS. This precise and reliable system not only achieves graft placement three times faster than traditional, funnel-based delivery methods, it also has a mechanism of action that is evidence backed.¹,² In fact, in a Level I human clinical study published in 𝑆𝑝𝑖𝑛𝑒, MagnetOs achieved nearly twice the fusion rate of autograft (𝟳𝟵% 𝘃𝘀. 𝟰𝟳%) in posterolateral fusions (PLFs).² Reach out to us today or watch the video to learn more about MagnetOs MIS: https://hubs.ly/Q03VmMGg0 #MinimallyInvasiveSpineSurgery #KurosBiosciences #MagnetOs #GrowBoneMagnetOs
Kuros Biosciences
Herstellung medizinischer Geräte
Schlieren, Zurich 10.619 Follower:innen
Grow Bone with MagnetOs
Info
OUR PURPOSE Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic technologies. OUR CREDENTIALS Kuros is a Swiss-headquartered biotech company, listed on the SIX Swiss Stock Exchange since 2016 (under symbol KURN). With additional operations in the Netherlands and the USA, we continue to grow our global team. To deliver the ideal bone graft, you need the highest quality and quantity of scientific evidence behind it. We believe that this is a key differentiator for Kuros, given the urgent need to advance bone healing. • Level 1 evidence published in Spine • 20 well-controlled Level I – IV clinical trials initiated or completed to date • >320 cumulative scientific papers, decades of research advancing bone graft innovation • >25 orthobiologic patents secured • >20 commercial markets serving spine, extremities, trauma and oncology • 12 U.S. FDA clearances granted to date, 12 expanding MagnetOs indications CONTACT KUROS TO FIND OUT MORE >>>>
- Website
-
http://www.kurosbio.com
Externer Link zu Kuros Biosciences
- Branche
- Herstellung medizinischer Geräte
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- Schlieren, Zurich
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- medical devices, orthobiologics, biotechnology, bone, spine, orthopedics, neurosurgery, foot & ankle, bone healing, spine surgery, musculoskeletal, orthopaedics, biologics und spine fusion
Orte
-
Primär
Wegbeschreibung
Wagistrasse 25
Schlieren, Zurich 8952, CH
-
Wegbeschreibung
10 Professor Bronkhorstlaan
Bilthoven, Bilthoven 3723MB, NL
-
Wegbeschreibung
10 Glenlake Parkway NE South Tower
Suite 150
Atlanta, Georgia 30328, US
Beschäftigte von Kuros Biosciences
-
Ralph van der Meer
Driving Digital Transformation with Dynamics 365 – One Process at a Time
-
Marco Sieber
Chief Information Officer & IT Interim Manager mit Leidenschaft für digitale, agile & IT-Transformationen
-
Johan-Pieter van Stempvoort, MSc MBA
COO level leader | Scaling high growth medical device start-ups | Driving operational Efficiency & profitability | Medical devices, Biotech and…
-
Remco Dalmeijer
Sr. Production Director Strategy at Kuros Biosciences B.V.
Updates
-
Some super sizzle at NASS and even a little drizzle in our coffee thanks to our custom MagnetOsᵀᴹ latte art! It was a privilege connecting with surgeons, distributors, and attendees who stopped by to share MagnetOs clinical insights and discuss how bone graft choices influence outcomes, especially in MIS! Thank you to everyone who spent time with us. Your engagement continues to shape how Kuros advances reliable options for predictable fusions. Learn more about MagnetOs MIS Delivery System here: https://lnkd.in/emfHPSJW
-
𝗪𝗵𝗮𝘁’𝘀 𝗱𝗿𝗶𝘃𝗶𝗻𝗴 𝗯𝗲𝘁𝘁𝗲𝗿 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀 𝗶𝗻 𝗺𝗶𝗻𝗶𝗺𝗮𝗹𝗹𝘆 𝗶𝗻𝘃𝗮𝘀𝗶𝘃𝗲 𝘀𝗽𝗶𝗻𝗲 𝘀𝘂𝗿𝗴𝗲𝗿𝘆 (𝗠𝗜𝗦)? Recent research by Ikwuegbueny et al. identifies advancements in surgical instrumentation and technologies, such as navigation systems and 3D visualization, which have significantly enhanced the success rates of MIS procedures.¹ To access the full study, click here: https://hubs.ly/Q03TWNgT0 The FDA-cleared MagnetOs MIS Delivery System supports successful MIS outcomes. Its long, narrow cannula is designed to fit easily within a tubular retractor, allowing for quick and optimal placement of MagnetOs. In a study by Davis et al., use of MagnetOs Easypack Putty in TLIF procedures resulted in a 94.4% fusion rate, with 85% of those procedures performed using MIS techniques.*² Meet the Expert to learn more: https://hubs.ly/Q03TWNCh0 *When used in intervertebral body fusion procedures, MagnetOs MIS and MagnetOs Easypack Putty must be used with an intervertebral body fusion device cleared by FDA for use with a bone void filler. Please refer to the Instructions for Use for a full list of indications, contraindications, precautions and warnings. Ikwuegbuenyi et al. 𝑁𝑒𝑢𝑟𝑜𝑠𝑢𝑟𝑔𝑒𝑟𝑦. 2025;96:S139–S147 Davis et al. 𝑂𝑟𝑡ℎ𝑜𝑝𝑒𝑑𝑖𝑐 𝑅𝑒𝑣𝑖𝑒𝑤. 2025;17
-
-
𝗞𝘂𝗿𝗼𝘀 𝗴𝗶𝘃𝗲𝘀 𝗯𝗮𝗰𝗸 𝗮𝘁 𝗡𝗔𝗦𝗦! This week, the Kuros Marketing team visited Ronald McDonald House Charities (RMHC) of Denver and left truly inspired by the impact they make every day. RMHC provides families traveling for critical medical care with a warm, safe, and supportive home, completely free of charge. As part of our visit, we hand-stuffed toy animals, added encouraging messages to their T-shirts, and placed them throughout the House for children to find. Last year, RMHC Denver supported thousands of families, ensuring no one faces a medical crisis alone. We’re grateful for the compassion and hope they bring to so many. As Kuros grows, we take as many opportunities as we can to support the communities we visit. Thank you, Hannah Bray for making this happen and thank you Kuros Marketing team for your commitment and dedication to improving lives every day!
-
-
𝗧𝗵𝗲 𝗻𝗲𝘄 𝗠𝗮𝗴𝗻𝗲𝘁𝗢𝘀™ 𝗠𝗜𝗦 𝗿𝗲𝗱𝗲𝗳𝗶𝗻𝗲𝘀 𝗯𝗼𝗻𝗲 𝗴𝗿𝗮𝗳𝘁 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆. Precise, predictable, and three times faster than traditional funnel-based delivery methods, with a mechanism of action that is evidence backed.¹,² In fact, in a Level I human clinical study published in 𝑆𝑝𝑖𝑛𝑒, MagnetOs achieved nearly twice the fusion rate of autograft (79% vs. 47%) in posterolateral fusions (PLFs).² Reach out to us today to learn more about MagnetOs MIS at: https://lnkd.in/e4XktH9f #MinimallyInvasiveSpineSurgery #KurosBiosciences #MagnetOs #GrowBoneMagnetOs
-
𝗟𝗼𝗼𝗸𝗶𝗻𝗴 𝗯𝗮𝗰𝗸 𝗼𝗻 𝗘𝗨𝗥𝗢𝗦𝗣𝗜𝗡𝗘 𝟮𝟬𝟮𝟱! Thank you to everyone who stopped by the Kuros booth to learn more about MagnetOs™, an advanced bone graft with predictable fusions. EUROSPINE gave us the chance to reconnect with familiar faces and meet new partners, all working toward better spinal fusion outcomes. 𝗜𝗳 𝘄𝗲 𝗺𝗶𝘀𝘀𝗲𝗱 𝘆𝗼𝘂 𝗶𝗻 𝗖𝗼𝗽𝗲𝗻𝗵𝗮𝗴𝗲𝗻, 𝘄𝗲’𝗱 𝘀𝘁𝗶𝗹𝗹 𝗹𝗼𝘃𝗲 𝘁𝗼 𝗰𝗼𝗻𝗻𝗲𝗰𝘁. 🤝 Reach out to us or visit https://hubs.ly/Q03SsYjK0 to learn more about how Kuros Biosciences is discovering, developing, and delivering innovative biologic technologies. #KurosBiosciences #EUROSPINE2025 #MagnetOs #GrowBoneMagnetOs
-
-
𝗛𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 #𝗡𝗔𝗦𝗦𝟮𝟬𝟮𝟱? Don’t miss the chance to hear from surgeons achieving MagnetOs™ results, including the newest MagnetOs MIS Delivery System. 📍 Stop by 𝗯𝗼𝗼𝘁𝗵 #𝟭𝟭𝟰𝟰 to meet: • Dr. Paul Johnson – Friday, Nov 14, 9–9:45am • Dr. Justin Davis – Saturday, Nov 15, 1–1:45pm Learn how MagnetOs is helping drive fusion success in both open and MIS procedures. #KurosBiosciences #MagnetOs #MIS #NASS2025 #GrowBoneMagnetOs
-
-
What if you could achieve graft placement and precise, predictable fusion in Minimally Invasive Surgery (MIS) three times faster than traditional, funnel-based delivery methods?¹ Seeing is believing. So, take a moment to learn how our new MagnetOs™ MIS bone graft delivery system delivers: https://lnkd.in/ezRWRNSq #MinimallyInvasiveSpineSurgery #KurosBiosciences #MagnetOs #GrowBoneMagnetOs
-
-
☕ 𝗪𝗵𝗲𝗿𝗲 𝗴𝗿𝗲𝗮𝘁 𝗰𝗼𝗳𝗳𝗲𝗲 𝗺𝗲𝗲𝘁𝘀 𝗴𝗿𝗲𝗮𝘁 𝘀𝗰𝗶𝗲𝗻𝗰𝗲. Join us at NASS 2025 where our in-booth barista will be crafting custom coffees while we share the latest insights on MagnetOs™ MIS and its role in advancing bone healing and MIS spinal fusion surgery. 📍 𝗕𝗼𝗼𝘁𝗵 #𝟭𝟭𝟰𝟰 🗓️ 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟭𝟰–𝟭𝟲 Stop by for a freshly brewed coffee and discover how MagnetOs is helping surgeons achieve reliable fusion. #NASS #MinimallyInvasiveSpineSurgery #KurosBiosciences #MagnetOs #GrowBoneMagnetOs
-
-
Kuros Biosciences hat dies direkt geteilt
It’s time to get a stronger grip on minimally invasive outcomes. The new MagnetOs™ MIS is engineered for optimal handling enabling easy, controlled, and precise graft positioning– even in narrow, hard-to-reach spaces. It reliably stays put after implantation, resists irrigation, and minimizes migration.¹,² Watch MagnetOs MIS precision in motion right here: https://hubs.ly/Q03QQVtt0 #MinimallyInvasiveSpineSurgery #KurosBiosciences #MagnetOs #GrowBoneMagnetOs
-
Verbundene Seiten
Ähnliche Seiten
Finanzierung
Letzte Runde
Kapitalerhöhung nach Börsengang6.237.719,00 $